AZD6793
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for AZD6793, covering 2025-05-31 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With Type 2 Diabetes Mellitus [Phase 1]